- Copel’s operating revenue for Q3 reached R$6.81 billion, marking a 19% increase compared to the same period last year.
- The estimated operating revenue was significantly lower at R$5.18 billion.
- Net income experienced a sharp decline of 69% year-over-year, coming in at R$383.1 million.
- EBITDA was recorded at R$1.36 billion, which is an 11% decrease compared to the previous year.
- The EBITDA margin fell from 26.6% last year to 19.9% this year.
- Market analysts have given Copel 15 buy ratings and 1 hold rating, with no sell ratings.
A look at Cia Paranaense De Energia Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 4 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on Smartkarma Smart Scores, Companhia Paranaense de Energia-Copel is showing a promising long-term outlook. With solid scores across various factors, including a 4 for Dividend and Momentum, investors can expect a company that is likely to provide stable returns and potentially attractive dividends in the future.
Companhia Paranaense de Energia-Copel, a key player in the Brazilian energy sector, holds a respectable position with its diversified portfolio of hydroelectric and thermoelectric plants. Serving a range of customers, from industrial to residential, the company’s operations in power generation, transmission, and distribution set a strong foundation for its continued growth and resilience in the market.
Summary: Companhia Paranaense de Energia-Copel is a significant electricity provider in the Brazilian state of Parana, catering to industrial, residential, and rural customers with a mix of hydroelectric and thermoelectric power plants.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
